Targeted Next-Generation Sequencing of 51 Genes Involved in Primary Electrical Disease

Dorien Proost1, Johan Saenen2, Geert Vandeweyer1

  • 1Center of Medical Genetics, Faculty of Medicine and Health Sciences, University of Antwerp and Antwerp University Hospital, Antwerp, Belgium.

Insights

A new genetic test accurately screens for primary electrical diseases (PED), a group of inherited heart rhythm disorders. This reliable assay identifies genetic variants, aiding in the diagnosis of cardiac arrhythmias and sudden cardiac death risk.

Area of Science:

  • Cardiovascular Genetics
  • Molecular Diagnostics
  • Genomic Medicine

Background:

  • Primary electrical disease (PED) comprises inherited cardiac arrhythmia syndromes.
  • These conditions can cause sudden cardiac death without apparent structural heart issues.
  • Diagnostic challenges arise from PED's clinical and genetic diversity.

Purpose of the Study:

  • To develop and validate a targeted gene panel for next-generation sequencing of 51 PED-associated genes.
  • To establish a reliable diagnostic tool for primary electrical diseases.

Main Methods:

  • Developed a targeted gene panel assay (PED Multiplex Amplification of Specific Targets for Resequencing Plus).
  • Utilized next-generation sequencing on MiSeq platform.
  • Validated the panel using 39 control samples, achieving 100% analytical sensitivity and 99.9% specificity.

Main Results:

  • Applied the validated assay to 114 PED patients.
  • Identified 107 variants across 36 genes.
  • Classified 18 variants as pathogenic/likely pathogenic, 54 as unknown significance, and 35 as likely benign.

Conclusions:

  • The developed assay is a proficient and highly reliable tool for routine screening of primary arrhythmias.
  • This genetic testing approach aids in diagnosing patients with primary electrical diseases.
  • The panel facilitates the identification of disease-causing variants in inherited cardiac arrhythmia syndromes.

Related Concept Videos

Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
55
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
351
Electrocardiogram01:29

Electrocardiogram

An electrocardiogram (ECG or EKG) is a critical diagnostic tool that records the electrical signals produced by the heart during each heartbeat. This recording is achieved through electrodes placed strategically on the arms, legs, and chest. The electrocardiograph amplifies these signals and produces 12 distinct tracings, offering a comprehensive understanding of the heart's electrical activity.
Three major waveforms are present in a typical ECG recording: the P wave, the QRS complex, and...
7.2K
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
16.2K